Scotch Whisky Investment Returns: What Two Years of Auction Data Actually Shows

Two years of systematic auction data from UK and European platforms paints a clear - and sometimes uncomfortable - picture of whisky as an investment asset. Not all bottles appreciate. Not all distilleries perform equally. And the costs of participation are higher than most published analyses acknowledge.

The Headline Numbers

Across the 2023-2024 period, rare Scotch whisky outperformed the FTSE 100 as an asset class, with the top quartile of tracked lots appreciating at an annualised rate of approximately 14-18%. However, the median lot - the average bottle at the average UK auction - appreciated by just 3-6%, barely ahead of inflation.

The distribution is the point. Whisky as an investment is not uniformly profitable. It is highly profitable for the right bottles and broadly break-even or loss-making for the wrong ones.

Which Distilleries Outperformed

The consistent outperformers shared three characteristics: limited annual production, a proven track record of at least 15 years, and a reputation for quality that transcends fashion cycles.

Springbank tops most lists for exactly these reasons. With production volumes that have not meaningfully grown in decades, genuine collector demand rather than speculative interest, and a distillery culture that refuses to compromise on process, Springbank bottlings consistently appreciated 15-25% annually across the tracked period. Brora - closed for much of its history and now producing again under strict constraints - showed similar characteristics driven by genuine scarcity.

Macallan occupies a category of its own. The upper tier (vintage Fine & Rare releases, M series) remains stratospherically valued with thin secondary liquidity. The mainstream Macallan range in current releases has appreciated more modestly, suggesting the brand premium is already largely priced in at the retail level - leaving less upside for investors buying at RRP.

The Distilleries That Disappointed

Japanese whisky was the most high-profile disappointment for investors who entered at 2021 peak prices. Yamazaki and Hibiki expressions that traded at 3-4x RRP during the speculation boom have corrected sharply, settling at 1.5-2x RRP - still above retail but a painful outcome for anyone who bought at the top.

Independent bottler releases showed highly mixed results. Established independents with strong reputations (Gordon & MacPhail, Signatory, Berry Bros) performed reasonably. Lesser-known independents with weaker provenance documentation underperformed significantly - the market's growing sophistication is brutal to anything that cannot demonstrate clear quality and authenticity.

The Hidden Costs That Erode Returns

Investment analyses of whisky routinely omit the frictional costs that materially erode returns:

• Auction buyer's premium: 15-24% of hammer price
• Seller's commission: typically 10-15% of hammer price
• Insurance and storage if holding for more than six months
• Opportunity cost of illiquid capital

Round-trip transaction costs alone - buying with premium and selling with commission - typically absorb 25-40% of the hammer price. A bottle needs to appreciate significantly just to reach break-even when all costs are accounted for. Most published whisky investment analyses ignore this entirely.

The Practical Implication

The data argues for concentrating on a small number of high-conviction positions in proven outperformers rather than building a broad portfolio of generic releases. Five well-researched bottles of demonstrably limited supply will outperform fifty bottles of average distillery releases - consistently, in the data.

It also argues strongly for buying at retail where possible and using auction data to time secondary market purchases - entering when prices have corrected and sentiment is neutral rather than at the top of a hype cycle driven by media coverage.